UKAD study finds 33% of 16-25-year-olds see SARMs ads weekly, raising concerns over unregulated online sales.
- UKAD warns SARMs ads target 16-25-year-olds on social media weekly
- One-third of young adults see performance enhancer ads despite health risks
- SARMs linked to liver damage, heart problems and hormonal imbalances
Social media platforms are flooded with ads for SARMs—selective androgen receptor modulators—a class of performance-enhancing drugs linked to serious health risks. A study by UK Anti-Doping UKAD reveals that 33% of 16-to-25-year-olds encounter SARMs promotions at least once a week. The findings underscore growing concerns about the unchecked sale of these substances online, often to young adults seeking muscle growth or athletic performance boosts.
Social media ‘wild west’ fuels SARMs sales
The UKAD research, published Monday, exposes how social media algorithms amplify SARMs marketing to vulnerable demographics. Unlike anabolic steroids, SARMs are sometimes sold as “legal” alternatives, exploiting loopholes in advertising and sales regulations. Vendors use coded language like “research chemicals” or “dietary supplements” to bypass oversight, researchers note. Instagram, TikTok, and Facebook remain hotspots for such promotions, despite platform policies against drug sales.
Health risks outweigh perceived benefits
Medical experts warn SARMs carry severe side effects—liver toxicity, heart strain, and hormonal disruptions—despite marketing claims of safety. Unlike FDA-approved treatments, SARMs are not regulated for human use. Dr. Luke Davies, UKAD’s Chief Medical Officer, said the drugs “pose serious, long-term health risks” and are not safe for non-medical use. Cases of acute liver failure and cardiac arrest have been reported in users, including amateurs.
Online sale surge linked to pandemic trends
The rise in SARMs availability coincides with a broader boom in online supplement sales during the COVID-19 pandemic. Fitness influencers and underground forums have normalized SARMs use, portraying them as quick fixes for physical appearance. UKAD’s survey of 2,000 people found 41% of respondents aged 18-24 had considered trying SARMs after seeing ads. Only 12% were aware of the health risks.
Regulators struggle to keep pace
UK agencies like the Medicines and Healthcare products Regulatory Agency MHRA have seized illegal SARMs shipments, but online vendors adapt rapidly. Platforms face pressure to enforce stricter ad policies and age restrictions. UKAD urges social media companies to remove SARMs promotions immediately and warns buyers that products may contain unlisted, hazardous ingredients.
UKAD plans to launch a public awareness campaign targeting gyms, universities, and social platforms. The organization also calls for stronger collaboration with online marketplaces to shut down illegal listings. Users tempted by SARMs are reminded: no shortcut in fitness is worth irreversible organ damage or life-threatening conditions.
What You Need to Know
- Source: BBC News
- Published: May 11, 2026 at 10:14 UTC
- Category: Health
- Topics: #bbc · #health · #medicine · #concern · #anti · #doping
Read the Full Story
This is a curated summary. For the complete article, original data, quotes and full analysis:
All reporting rights belong to the respective author(s) at BBC News. GlobalBR News summarizes publicly available content to help readers discover the most relevant global news.
Curated by GlobalBR News · May 11, 2026
Related Articles
- Why ‘Ballmaxxing’ May Be More Dangerous Than You Think
- Weight Loss Surgeries Decline as GLP-1 Use Skyrockets. Why This Matters
- Olympian Allyson Felix on Why Rest and Recovery Beat Hustle Culture
🇧🇷 Resumo em Português
Mais de 30% dos jovens brasileiros entre 16 e 25 anos são expostos semanalmente a propagandas de SARMs, substâncias proibidas que prometem resultados rápidos no ganho de massa muscular, segundo um estudo recente da UK Anti-Doping. A pesquisa, que alerta para os riscos desses compostos, revela uma tendência perigosa entre adolescentes e adultos jovens, que muitas vezes buscam alternativas “milagrosas” para melhorar a aparência física ou performance esportiva.
No Brasil, onde o uso de suplementos e anabolizantes já é uma preocupação crescente entre os jovens, a facilidade de acesso a essas substâncias pela internet agrava o problema. Os SARMs, apesar de não serem aprovados para uso humano, são comercializados livremente em sites e redes sociais, muitas vezes com apelos enganosos sobre segurança e eficácia. Especialistas brasileiros em saúde pública destacam que o uso indiscriminado pode causar danos irreversíveis ao fígado, ao coração e ao sistema hormonal, além de aumentar o risco de dependência química.
Para combater esse cenário, o próximo passo é a fiscalização mais rigorosa das plataformas digitais e campanhas de conscientização direcionadas aos jovens, que muitas vezes desconhecem os perigos dessas substâncias.
🇪🇸 Resumen en Español
El auge de las redes sociales y el comercio digital ha convertido en algo cotidiano para los jóvenes encontrar publicidad de suplementos y potenciadores de rendimiento, pero bajo esa apariencia inofensiva se esconden sustancias peligrosas como los SARMs.
Una investigación de la Agencia Antidopaje del Reino Unido revela que uno de cada tres adultos jóvenes en ese país —específicamente entre 16 y 25 años— se expone semanalmente a anuncios de SARMs, unos moduladores selectivos de los receptores de andrógenos que prometen aumentar la masa muscular y mejorar el rendimiento físico sin los efectos secundarios típicos de los esteroides tradicionales. Aunque su venta en línea se presenta como legal y segura, la realidad es que su consumo conlleva riesgos graves para la salud, como daño hepático, alteraciones hormonales e incluso problemas cardiovasculares. Para los hispanohablantes, especialmente en contextos donde el acceso a estos productos puede ser más opaco debido a la regulación desigual, el mensaje es claro: la tentación de resultados rápidos en el gimnasio no justifica poner en riesgo el bienestar a largo plazo.
BBC News
Read full article at BBC News →This post is a curated summary. All rights belong to the original author(s) and BBC News.
Was this article helpful?
Discussion